Targeting of p38 mitogen-activated protein kinases to MEF2 transcription factors
about
Differential localization of HDAC4 orchestrates muscle differentiationERK5 is targeted to myocyte enhancer factor 2A (MEF2A) through a MAPK docking motifThe Notch coactivator, MAML1, functions as a novel coactivator for MEF2C-mediated transcription and is required for normal myogenesisMirk/Dyrk1B mediates survival during the differentiation of C2C12 myoblastsp300/cAMP-response-element-binding-protein ('CREB')-binding protein (CBP) modulates co-operation between myocyte enhancer factor 2A (MEF2A) and thyroid hormone receptor-retinoid X receptorIdentification of a docking groove on ERK and p38 MAP kinases that regulates the specificity of docking interactions.Id helix-loop-helix proteins antagonize pax transcription factor activity by inhibiting DNA bindingp38 and extracellular signal-regulated kinases regulate the myogenic program at multiple stepsExtracellular signal-regulated kinase binds to TFII-I and regulates its activation of the c-fos promoterSpecificity of linear motifs that bind to a common mitogen-activated protein kinase docking grooveSubstrate discrimination among mitogen-activated protein kinases through distinct docking sequence motifsAdaptable molecular interactions guide phosphorylation of the SR protein ASF/SF2 by SRPK1Deletion of calcineurin and myocyte enhancer factor 2 (MEF2) binding domain of Cabin1 results in enhanced cytokine gene expression in T cellsSignal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylasesKnockout of ERK5 causes multiple defects in placental and embryonic developmentIdentification of mitogen-activated protein kinase docking sites in enzymes that metabolize phosphatidylinositols and inositol phosphates.Regulation of the yeast Rlm1 transcription factor by the Mpk1 cell wall integrity MAP kinase.MEKK2 associates with the adapter protein Lad/RIBP and regulates the MEK5-BMK1/ERK5 pathwayActivation of MEF2 by muscle activity is mediated through a calcineurin-dependent pathwayThe NADPH oxidase NOX4 drives cardiac differentiation: Role in regulating cardiac transcription factors and MAP kinase activationA p38 MAPK-MEF2C pathway regulates B-cell proliferationEssential role for p38alpha mitogen-activated protein kinase in placental angiogenesisDynamic single cell measurements of kinase activity by synthetic kinase activity relocation sensorsSeparating myoblast differentiation from muscle cell fusion using IGF-I and the p38 MAP kinase inhibitor SB202190.Wnt-mediated down-regulation of Sp1 target genes by a transcriptional repressor Sp5.Functional classification of proteins based on projection of amino acid sequences: application for prediction of protein kinase substrates.Ser484 and Ser494 in REL are the major sites of IKK phosphorylation in vitro: evidence that IKK does not directly enhance GAL4-REL transactivation.Arabidopsis MKS1 is involved in basal immunity and requires an intact N-terminal domain for proper function.Characterization of ERK docking domain inhibitors that induce apoptosis by targeting Rsk-1 and caspase-9.Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinasesHerpes simplex virus ICP27 activation of stress kinases JNK and p38.Disruption of chaperone-mediated autophagy-dependent degradation of MEF2A by oxidative stress-induced lysosome destabilization.The ternary complex factor Net contains two distinct elements that mediate different responses to MAP kinase signalling cascades.Caspase 3 activity is required for skeletal muscle differentiation.Docking sites on mitogen-activated protein kinase (MAPK) kinases, MAPK phosphatases and the Elk-1 transcription factor compete for MAPK binding and are crucial for enzymic activity.Activation of ERK induces phosphorylation of MAPK phosphatase-7, a JNK specific phosphatase, at Ser-446.MEF2 responds to multiple calcium-regulated signals in the control of skeletal muscle fiber type.MEK kinase 2 and the adaptor protein Lad regulate extracellular signal-regulated kinase 5 activation by epidermal growth factor via SrcCurcumin prevents lipopolysaccharide-induced atrogin-1/MAFbx upregulation and muscle mass loss.Molecular profiles of mitogen activated protein kinase signaling pathways in orofacial development.
P2860
Q24291565-7EF03AAA-4707-43BC-A8F8-5B667009A830Q24292700-97596BF2-F574-4F92-A002-342F9518796CQ24306223-B4CE3B7A-5EDC-4A19-8DE6-E4107B0AFBB9Q24532054-E79A10A4-D0D3-4040-8410-BC9EE0DE72FCQ24535129-C4DE9F4C-2F2E-41C7-89ED-4588B5213273Q24536356-D037A3DE-8A34-400C-B77F-C30273B85319Q24551030-A650A92B-0FCC-463D-83BB-04032A038C43Q24554203-25B2F77A-E389-4BFF-BEA1-C9247B6226D2Q24554321-A9272870-53DA-4BC2-BFDE-FA1E449109B4Q24610682-44D52649-9F9A-41F3-A80D-0633F84B0012Q24647635-BCC62B50-1CA2-4208-9F4C-C99C55633612Q24657372-1F9CCF5E-2D6A-4BCA-B25B-E54BADE6944EQ24674634-060B62D9-5DF5-4D56-B100-14B6D7A1AA0AQ24682791-0486CF82-05E1-40C5-AC56-BF57E8B8CB5CQ24791222-5DD267CB-0CA3-4A62-85D2-7AEC5CB464CBQ25255706-9381FAED-3364-4942-9F64-926CA6B63869Q27936197-518B11E0-56C0-4E3D-BCF1-B6E2DAD4EAB1Q28143630-DCC25780-3AE0-4DD9-B576-133B6D55401DQ28364039-FC7F1A68-C20B-4F40-9908-F773051EF68AQ28510993-A4B0F215-9CDA-4744-BCCE-613E4B1EBDA1Q28588781-29E33358-DCDC-4AA6-8C4C-2D625ACB2907Q28594675-5A6B3DFF-D4A8-447E-9B8A-38AF24C2E9D4Q30659597-8F82F365-D816-497A-B9A8-E44F0CCCF87CQ30666846-016AA770-B756-4B23-A04D-9F098A340DF7Q32874844-9A6836AE-C5F9-41C7-A473-0637AA4B778CQ33600276-455E1C6E-66D0-4C50-98A7-1AA4B65231E9Q33658906-59AD293B-5F53-436F-BC33-00A0A5444507Q33784441-25911ECA-7334-44CA-B0DD-55615F205967Q33789572-38757074-DE33-4E66-A107-537C7085B4C5Q33793163-64A5FA06-C598-4324-B0B3-4D2CB68C1442Q33843399-F773307C-3000-4051-B2C6-2D0450E5575DQ33878919-681F4201-2D88-4613-9906-61F2905E7A46Q33922446-1618C2A9-D6B6-4CEC-BCD6-0B28DAA042ABQ34036654-0E00C2FC-8690-4908-AEC7-D3C149A74000Q34170648-7E5F21EB-F3EF-42DC-9BF9-6C9BDB8FD157Q34204142-123A230A-4AFE-4E92-B822-BEC268729EEBQ34669135-6F62DFAA-F79D-43D5-AE81-AD64065C442BQ34783859-F32DFAE6-420C-48DB-A02E-5636A6CF81C2Q34997519-BF9F5502-E9BD-417D-9546-4A6FE46518A7Q35073208-CF9AC493-44E8-4024-ACDB-F73EFD3147AF
P2860
Targeting of p38 mitogen-activated protein kinases to MEF2 transcription factors
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Targeting of p38 mitogen-activated protein kinases to MEF2 transcription factors
@ast
Targeting of p38 mitogen-activated protein kinases to MEF2 transcription factors
@en
Targeting of p38 mitogen-activated protein kinases to MEF2 transcription factors
@en-gb
Targeting of p38 mitogen-activated protein kinases to MEF2 transcription factors
@nl
type
label
Targeting of p38 mitogen-activated protein kinases to MEF2 transcription factors
@ast
Targeting of p38 mitogen-activated protein kinases to MEF2 transcription factors
@en
Targeting of p38 mitogen-activated protein kinases to MEF2 transcription factors
@en-gb
Targeting of p38 mitogen-activated protein kinases to MEF2 transcription factors
@nl
prefLabel
Targeting of p38 mitogen-activated protein kinases to MEF2 transcription factors
@ast
Targeting of p38 mitogen-activated protein kinases to MEF2 transcription factors
@en
Targeting of p38 mitogen-activated protein kinases to MEF2 transcription factors
@en-gb
Targeting of p38 mitogen-activated protein kinases to MEF2 transcription factors
@nl
P2093
P2860
P921
P3181
P356
P1476
Targeting of p38 mitogen-activated protein kinases to MEF2 transcription factors
@en
P2093
A D Sharrocks
P2860
P304
P3181
P356
10.1128/MCB.19.6.4028
P407
P577
1999-06-01T00:00:00Z